Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...

Long-term Potentiation

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when presynaptic neurons...

Long-term Potentiation

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dynamic single-cell transcriptomic analysis of peripheral blood mononuclear cells identifies novel biomarkers for autoimmune encephalitis.

Molecular psychiatry·2026

Same author

The criticome as the window of becoming: Toward a novel and comprehensive framework for understanding the critical period of information integration in human development.

Brain health : lifelong brain resilience and longevity·2026

Same author

Evolution of the Neurometabolic Cascade of Traumatic Brain Injury.

Neurologic clinics·2026

Same author

Phosphate homeostasis and apparent treatment-resistant hypertension in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study.

Hypertension research : official journal of the Japanese Society of Hypertension·2026

Same author

Return-to-school protocols in pediatric concussion care.

Seminars in pediatric neurology·2026

Same author

The human microplastic burden and brain health: From measurement to pathophysiology and removal.

Brain health : lifelong brain resilience and longevity·2026

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

Selective Depletion of Microglia from Cerebellar Granule Cell Cultures Using L-leucine Methyl Ester

Selective Depletion of Microglia from Cerebellar Granule Cell Cultures Using L-leucine Methyl Ester

Published on: July 7, 2015

Leptin replacement improves cognitive development.

Gilberto J Paz-Filho¹, Talin Babikian, Robert Asarnow

¹Department of Psychiatry and Behavioral Sciences, Center for Pharmacogenomics, University of Miami Miller School of Medicine, Miami, Florida, USA.

|September 5, 2008

Summary

Leptin replacement therapy improved neurocognitive development rates in a child with a leptin gene mutation. This suggests leptin may enhance cognitive function in the developing brain.

Related Experiment Videos

Last Updated: Jul 2, 2026

Selective Depletion of Microglia from Cerebellar Granule Cell Cultures Using L-leucine Methyl Ester

Selective Depletion of Microglia from Cerebellar Granule Cell Cultures Using L-leucine Methyl Ester

Published on: July 7, 2015

Area of Science:

Neuroendocrinology
Developmental Neuroscience
Metabolic Disorders

Background:

Leptin regulates feeding circuits and brain development, but its impact on neurocognitive development is not well understood.
A child with a leptin gene mutation presented with obesity and developmental delays.

Observation:

The patient received recombinant methionyl human leptin (r-metHuLeptin) treatment.
Cognitive development was assessed using Differential Ability Scales (DAS) and NEPSY.
Baseline assessments showed developmental age was lower than chronological age in most areas.

Findings:

After two years of leptin replacement therapy, significant improvements in neurocognitive development rates were observed.
Some cognitive skills reached or exceeded age-expected levels.
The patient experienced weight loss and resolution of associated metabolic and cardiovascular issues.

Implications:

Leptin replacement therapy may offer a cognitive-enhancing role in the developing central nervous system.
This study supports leptin's broader function beyond metabolism, impacting neurodevelopment.
Further research into leptin's neurocognitive effects is warranted.